Suppr超能文献

提取物和虫草素通过调节肠道微生物群和代谢产物来改善2型糖尿病。

extracts and cordycepin ameliorate type 2 diabetes mellitus by modulating the gut microbiota and metabolites.

作者信息

Liu Xinyuan, Dun Mengqian, Jian Tongtong, Sun Yuqing, Wang Mingyu, Zhang Guoying, Ling Jianya

机构信息

State Key Laboratory of Microbial Technology, Shandong University, Qingdao, SD, China.

Shandong University of Traditional Chinese Medicine, Jinan, SD, China.

出版信息

Front Pharmacol. 2023 Mar 9;14:1134429. doi: 10.3389/fphar.2023.1134429. eCollection 2023.

Abstract

, which has many potential medicinal properties, has rarely been reported to alleviate type 2 diabetes mellitus (T2DM). The effects of extracts (CE) and cordycepin (CCS) on high-fat diet and streptozotocin (STZ) induced T2DM mice were analysed by gut microbiome and metabolomics methods in this study. The results demonstrated that glucose and lipid metabolism parameters, oxidative stress biomarkers and inflammation cytokines were down-regulated in the CCS and CE groups. A comparative analysis of the fecal samples from mice in the model and experimental groups showed that experimental groups resulted in a higher abundance of Firmicutes/Bacteroidetes. This study provides evidence that can be used as a food supplement to relieve T2DM, which provides a promising prospect for new functional food in it.

摘要

具有许多潜在药用特性的[具体物质未提及],很少有报道称其可缓解2型糖尿病(T2DM)。本研究通过肠道微生物组和代谢组学方法分析了[具体物质未提及]提取物(CE)和虫草素(CCS)对高脂饮食和链脲佐菌素(STZ)诱导的T2DM小鼠的影响。结果表明,CCS组和CE组的葡萄糖和脂质代谢参数、氧化应激生物标志物和炎症细胞因子均下调。对模型组和实验组小鼠粪便样本的比较分析表明,实验组导致厚壁菌门/拟杆菌门的丰度更高。本研究提供了证据表明[具体物质未提及]可作为缓解T2DM的食品补充剂,这为其中新型功能性食品提供了广阔前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf9/10033974/97ebf0aec14a/fphar-14-1134429-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验